WildBio
PrivateLast Round
Series A
Oct 16, 2025
Total Funding Raised
$85.71M
Company Overview
WildBio is a biotechnology company that operates a cell biobank with a diverse array of African species cell lines, enabling the foodtech and biomedical sectors to create sustainable innovations.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WildBio Comps
Public and private peers based on sector, stage, and business model.
WildBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2025 | ||||
| Grant | Jun 2, 2025 | ||||
| Grant | Jul 1, 2021 |
WildBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braavos Investment Advisers | Seed, Series A |
| Oxford Science Enterprises | Seed, Series A |
| University of Oxford | Seed, Series A |
| Innovate UK | Grant |
| Advanced Research and Invention Agency | Grant |
| Ellison Institute of Technology | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
$60M round led by Ellison Institute of Technology
- Jun 2, 2025
$9.1M grant from Advanced Research and Invention Agency.
WildBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about WildBio's valuation, stock price, and market status.
